Integration of human papillomavirus (HPV) into the host genome is regarded as a determining
event in cervical carcinogenesis. However, the exact mechanism for integration, and the …

Background In 2009, quadrivalent human papillomavirus (HPV) vaccine was introduced in
a school-based single-cohort program targeting 12-year-old girls in Norway. We estimated …

Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …

Background The VALidation of HPV GENoyping Tests (VALGENT) is an international initiative
designed to validate HPV assays with genotyping capability. The VALGENT4 protocol …

Human papillomaviruses (HPVs) co-evolve slowly with the human host and each HPV genotype
displays epithelial tropisms. We assessed the evolution of intra HPV genotype variants …

Background & aim Women with HIV/HPV coinfection and cervical lesions are at increased
risk of developing HPV related anal cancer. Self-collection of anal swabs may facilitate HPV …

Human papillomavirus (HPV) 16 and 18 are the most predominant types in cervical cancer.
Only a small fraction of HPV infections progress to cancer, indicating that additional factors …

Background Many countries have initiated school-based human papillomavirus (HPV)
vaccination programs. The real-life effectiveness of HPV vaccines has become increasingly …

HPV genomic variability and chromosomal integration are important in the HPV-induced
carcinogenic process. To uncover these genomic events in an HPV infection, we have …

Background: Cervical cancer screening programs are facing a programmatic shift where
screening protocol based on human papillomavirus testing (HPV-Screening protocol) is …